ONC establishes database to build workgroup membership

Luke Gale | | Health Exec | Policy & Regulations

The Office of the National Coordinator for Health IT (ONC) has established an online database to recruit participants for and publicize its health IT advisory committee workgroup.

Charged with providing recommendations to the national coordinator in a number of areas, including standards, implementation specifications and health information exchange policy, ONC workgroup members play an important role in the smooth implementation of the federal health IT strategic plan, according to an Oct. 10 statement published in the Federal Register.

Individuals interested in becoming actively involved with these efforts are invited to submit via the database their information for future consideration. As new workgroups are created and existing ones experience turnover, the ONC will turn to the database first to fill out each group’s membership.

For more information, visit the ONC database. 

Luke Gale

Related Content

Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
10 signs AI is ‘eating the world (of venture capital)’
Mangione now faces federal charges, death penalty in murder of UHC CEO
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
DOJ sues CVS over unlawful opioid prescriptions and reimbursement

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.